Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 129, 2023 - Issue 5
93
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Usefulness of different adiposity indexes for identification of metabolic disturbances in patients with obesity

, &
Pages 1105-1110 | Received 02 Jan 2021, Accepted 01 Mar 2021, Published online: 12 May 2021

References

  • Amato, M., et al., 2010. Visceral Adiposity Index: a reliable indicator of visceral fat functionassociated with cardiometabolic risk. Diabetes care, 33 (4), 920–922.
  • Arancibia, C., et al., 2014. Evaluation of serum insulin levels after an oral glucose load for the diagnosis of insulin resistance. Revista Médica de Chile, 142 (9), 1106–1112.
  • Ascaso, J., et al., 2003. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes care, 26 (12), 3320–3325.
  • Ascaso, J.F., et al., 2001. Insulin resistance quantification by fasting insulid plasma values and HOMA index in non diabetic population. Medicina Clínica, 117, 530–533.
  • Bello-Chavolla, O.Y., et al., 2018. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. European journal of endocrinology, 178 (5), 533–544.
  • Boden, G., 1997. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes, 46, 3–10.
  • Brahimaj, A., et al., 2019. Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study. Diabetologia, 62 (9), 1581–1590.
  • Chen, C., et al., 2014. The application of visceral adiposity index in identifying type 2 diabetes risks based on a prospective cohort in China. Lipids in health and disease, 13 (1), 108.
  • Conroy, R.M., et al., 2003. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projects. European heart journal, 24 (11), 987–1003.
  • Dobiasova, M. and Frohlich, J., 2001. The plasma parameterlog (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size andesterification rate in apoB-lipoprotein-depletedplasma (FER(HDL)). Clinical biochemistry, 34, 583–588.
  • European Society of Cardiology., 2019. SCORE Risk charts. Available from: https://www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/SCORE-Risk-Charts [accessed 25 September 2019].
  • Fantuzzi, G. and Mazzone, T., 2007. Adipose tissue and atherosclerosis: exploring the connection. Arteriosclerosis, thrombosis, and vascular biology, 27, 996–1003.
  • Freemantle, N., et al., 2008. How strong is the association between abdominal obesity and the incidence of type 2 diabetes? International journal of clinical practice, 62 (9), 1391–1396.
  • Gateva, A. and Kamenov, Z., 2012. Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome. European journal of obstetrics & gynecology and reproductive biology, 164 (2), 161–166.
  • Gomez-Marcos, M., et al., 2019. Capacity adiposity indices to identify metabolic syndrome in subjects with intermediate cardiovascular risk (MARK study). PLoS One, 14 (1), e0209992.
  • Hadaegh, F., Shafiee, G., and Azizi, F., 2009. Anthropometric predictors of incident type 2 diabetes mellitus in Iranian women. Annals of Saudi medicine, 29 (3), 194–200.
  • Kahn, H.S. and Valdez, R., 2003. Metabolic risks identified bythe combination of enlarged waist and elevatedtriacylglycerol concentration. The American journal of clinical nutrition, 78 (5), 928–934.
  • Kissebah, A.H., et al., 1982. Relation of body fat distribution to metabolic complications of obesity. Journal of clinical endocrinology and metabolism, 54, 254–260.
  • Kissebah, A.H. and Krakower, G.R., 1994. Regional adiposity and morbidity. Physiological reviews, 74, 761–811.
  • Kouli, G., et al., 2017. Visceral adiposity index and 10-year cardiovascular disease incidence: the ATTICA study. Nutrition, metabolism and cardiovascular diseases, 27 (10), 881–889.
  • Krakauer, N.Y. and Krakauer, J.C., 2012. A new body shape indexpredicts mortality hazard independently of bodymass index. PLoS one, 7, e39504.
  • Krakauer, N.Y. and Krakauer, J.C., 2016. An anthropometric risk index based on combining height, weight, waist, and hip measurements. Journal of obesity, 2016, 8094275.
  • Krotkiewski, M., et al., 1983. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. Journal of clinical investigation, 72, 1150–1162.
  • Nusrianto, R., et al., 2019. Visceral adiposity index and lipid accumulation product as a predictor of type 2 diabetes mellitus: the Bogor cohort study of non-communicable diseases risk factors. Diabetes research and clinical practice, 155, 107798.
  • Ohlson, L.O., et al., 1985. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes, 34 (10), 1055–1058.
  • Park, Y., et al., 2018. A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Scientific reports, 8 (1), 16753.
  • Piepoli, M.F., Hoes, A.W., and Agewall, S., 2016. European guidelines on cardiovascular disease prevention in clinical practice. European heart journal, 37 (29), 2315–2381.
  • Poirier, P., et al., 2006. Obesity and cardiovascular disease: pathophysiology, evaluation and effect of weight loss. Circulation, 113, 898–918.
  • Saely, C., et al., 2018. The visceral adiposity index predicts cardiovascular events both in cardiovascular disease patients with and in those without diabetes. Diabetes, 67 (1), 2091.
  • Thomas, D.M., et al., 2013. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity, 21 (11), 2264–2271.
  • Wei, J., et al., 2019. Comparisons of visceral adiposity index, body shape index, body mass index and waist circumference and their associations with diabetes mellitus in adults. Nutrients, 11 (7), 1580.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.